Rui Ding

Rui Ding is a Senior Scientist in Clinical Pharmacology at Servier since October 2021, and serves as a DMPK Representative/Senior Scientist at Agios Pharmaceuticals since December 2018. Prior to these roles, Rui Ding worked as a Research Associate at the Rutgers Cancer Institute of New Jersey from July 2013 to November 2018, where significant contributions included discovering a novel role of ABCG2 in regulating autophagy across various cancer types and identifying binding partners of ABCG2 through proteomics and biochemistry. Rui Ding achieved a Doctor of Philosophy (Ph.D.) in Pharmacology from Rutgers University and holds a Bachelor's degree in Biotechnology from Nankai University.